Red: The reason I posted many times about Jason's low ball LymPro estimate was because it was a very relevant topic that made a big difference in our stock price! Two massive catalysts were announced afterwards that didn't budge the stock price: 1) RP Orphan, and 2) Lympro Launch!

My posts were spot on! I'll say this also, if Gerald announces decent LP002 Lympro numbers this month but doesn't give adequate evidence pharmas are signing up yet....the stock price won't budge this time either!!

The market won't give a damn about our therapeutic drugs that are years away from commercialization unless Lympro starts showing signs it can offset dilution! In the near term, news pertaining to Lympro revenue is about the only thing that will move our stock price.

Gerald has yet to remove the stumbling block Jason placed in our path. Hopefully he does that soon!